Erratum: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression (Stem Cell Res Ther. (2015) 6 (140) DOI: 10.1186/s13287-015-0127-9);Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression

Stem Cell Research and Therapy

Volumn 6, Issue 1, 2015, Pages

  Kizilay Mancini, Ozge ^a   Shum Tim, Dominique ^b   Stochaj, Ursula ^a   Correa, José A ^a   Colmegna, Inés ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ARTICLE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE REPLACEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STROMA CELL; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SUBCUTANEOUS FAT; T LYMPHOCYTE; ADIPOSE TISSUE; AGE; AGED; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; METABOLISM; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADIPOSE TISSUE; AGE FACTORS; AGED; ATHEROSCLEROSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LINEAR MODELS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84938685482     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-017-0504-7     Document Type: Erratum

References (21)

1. D'Agostino Sr RB, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Global Heart. 2013;8:11-23. doi: 10.1016/j.gheart.2013.01.001.
2. Hedrick CC. Lymphocytes in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:253-7. doi: 10.1161/ATVBAHA.114.305144.
3. Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi AC, De Metrio M, et al. Effector memory T cells are associated with atherosclerosis in humans and animal models. J Am Heart Assoc. 2012;1:27-41. doi: 10.1161/JAHA.111.000125.
4. De Palma R, Del Galdo F, Abbate G, Chiariello M, Calabro R, Forte L, et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: evidence for a local, intracoronary immunologic mechanism. Circulation. 2006;113:640-6. doi: 10.1161/CIRCULATIONAHA.105.537712.
5. Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res. 2014;102:107-17. doi: 10.1093/cvr/cvu002.
6. Karantalis V, Hare JM. Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res. 2015;116:1413-30. doi: 10.1161/CIRCRESAHA.116.303614.
7. Perin EC, Sanz-Ruiz R, Sanchez PL, Lasso J, Perez-Cano R, Alonso-Farto JC, et al. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: the PRECISE Trial. Am Heart J. 2014;168:88-95. doi: 10.1016/j.ahj.2014.03.022.e2.
8. Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;10:244-58. doi: 10.1016/j.stem.2012.02.005.
9. Li XY, Ding J, Zheng ZH, Li XY, Wu ZB, Zhu P. Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells. Mol Med Rep. 2012;6:1183-9. doi: 10.3892/mmr.2012.1039.
10. Landgraf K, Brunauer R, Lepperdinger G, Grubeck-Loebenstein B. The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age. Transpl Immunol. 2011;25:167-72. doi: 10.1016/j.trim.2011.06.007.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-7. doi: 10.1080/14653240600855905.
12. Barrett L, Dai C, Gamberg J, Gallant M, Grant M. Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10. J Leukoc Biol. 2007;82:152-60. doi: 10.1189/jlb.0806521.
13. Bloom DD, Centanni JM, Bhatia N, Emler CA, Drier D, Leverson GE, et al. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. Cytotherapy. 2015;17:140-51. doi: 10.1016/j.jcyt.2014.10.002.
14. Houtgraaf JH, den Dekker WK, van Dalen BM, Springeling T, de Jong R, van Geuns RJ, et al. First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59:539-40. doi: 10.1016/j.jacc.2011.09.065.
15. Liang H, Hou H, Yi W, Yang G, Gu C, Lau WB, et al. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury. Eur Heart J. 2013;34:1681-90. doi: 10.1093/eurheartj/ehr131.
16. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29-36. doi: 10.1016/S0140-6736(06)68967-8.
17. Moll G, Alm JJ, Davies LC, von Bahr L, Heldring N, Stenbeck-Funke L, et al. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem cells. 2014. doi: 10.1002/stem.1729.
18. Efimenko A, Dzhoyashvili N, Kalinina N, Kochegura T, Akchurin R, Tkachuk V, et al. Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential. Stem Cells Transl Med. 2014;3:32-41. doi: 10.5966/sctm.2013-0014.
19. Haack-Sorensen M, Friis T, Mathiasen AB, Jorgensen E, Hansen L, Dickmeiss E, et al. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant. 2013;22:521-8. doi: 10.3727/096368912X636830.
20. Liu Y, Liu T, Han J, Yang Z, Xue X, Jiang H, et al. Advanced age impairs cardioprotective function of mesenchymal stem cell transplantation from patients to myocardially infarcted rats. Cardiology. 2014;128:209-19. doi: 10.1159/000360393.
21. Zhang Z, Zhao C, Liu B, Liang D, Qin X, Li X, et al. Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res Ther. 2014;5:33. doi: 10.1186/scrt431.